Activation-dependent surface expression of LOX-1 in human platelets

Biochemical and Biophysical Research Communications

Volumn 282, Issue 1, 2001, Pages 153-158

  Chen, Mingyi ^a,b   Kakutani, Makoto ^a   Masaki, Tomoh ^a   Sawamura, Tatsuya ^a,e   Narumiya, Shuh ^b   Naruko, Takahiko ^c   Ueda, Makiko ^d  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d OSAKA CITY GENERAL HOSPITAL   (Japan)

^e OSAKA UNIVERSITY   (Japan)

Author keywords

Human platelet; LOX 1; Oxidized LDL

Indexed keywords

LECTIN; LOW DENSITY LIPOPROTEIN RECEPTOR; MEMBRANE PROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; UNCLASSIFIED DRUG;

ARTICLE; ATHEROSCLEROTIC PLAQUE; CELL SURFACE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN LOCALIZATION; SMOOTH MUSCLE FIBER; THROMBOCYTE ACTIVATION; THROMBOGENESIS; THROMBUS; UNSTABLE ANGINA PECTORIS;

ANGINA; THROMBUS;

EID: 0034813624     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2001.4516     Document Type: Article

References (31)

1. An endothelial receptor for oxidized low-density lipoprotein
2. NKR-P1, a signal transduction molecule on natural killer cells
3. Structure and chromosomal assignment of the human lectin-like oxidized low-density-lipoprotein receptor-1 (LOX-1) gene
4. A sequence-ready physical map of the region containing the human natural killer gene complex on chromosome 12p12.3-p13.2
5. Lectin-like oxidized low-density lipoprotein receptor 1 mediates phagocytosis of aged/apoptotic cells in endothelial cells
6. A novel platelet-endothelium interaction mediated by lectin-like oxidized LDL receptor-1
7. The pathogenesis of atherosclerosis: A perspective for the 1990s
8. Antisense to LOX-1 inhibits oxidized LDL-mediated upregulation of monocyte chemoattractant protein-1 and monocyte adhesion to human coronary artery endothelial cells
9. Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-kappaB through an increased production of intracellular reactive oxygen species
10. Platelet activation by oxidatively modified low density lipoproteins
11. Role of lipoproteins in platelet activation
12. Functional morphological alterations of human blood platelets induced by oxidized low density lipoprotein
13. Oxidized LDL induces serotonin release from blood platelets
14. Adhesion of washed blood platelets in vitro is advanced, accelerated, and enlarged by oxidized low-density lipoprotein
15. CD36 is a receptor for oxidized low density lipoprotein
16. Human platelets exclusively bind oxidized low density lipoprotein showing no specificity for acetylated low density lipoprotein
17. Significance of membrane glycoproteins in platelet interaction with oxidized low-density lipoprotein
18. Recombinant glutathione S-transferase/CD36 fusion proteins define an oxidized low density lipoprotein-binding domain
19. Rapid fluorometric assay of LDL receptor activity by DiI-labeled LDL
20. Both Ets-1 and GATA-1 are essential for positive regulation of platelet factor 4 gene expression
21. Increased expression of lectin-like oxidized low density lipoprotein receptor-1 in initial atherosclerotic lesions of Watanabe heritable hyperlipidemic rabbits
22. Identification of the lectin-like receptor for oxidized low-density lipoprotein in human macrophages and its potential role as a scavenger receptor
23. Practical successful immunoenzyme double-staining experiments
24. Proteoglycan synthesis in human erythroleukaemia (HEL) cells
25. Expression of lectin-like oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions
26. Expression of lectin-like oxidized low density lipoprotein receptor-1 in human and murine macrophages: Upregulated expression by TNF-alpha
27. The expression the lectin-like oxidized low-density lipoprotein receptor (LOX-1) on human vascular smooth muscle cells and monocytes and its down-regulation by lovastatin
28. Interactions of platelets, macrophages, and lipoproteins in hypercholesterolemia: Antiatherogenic effects of HMG-CoA reductase inhibitor therapy
29. Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions
30. Oxidized LDL decreases L-arginine uptake and nitric oxide synthase protein expression in human platelets: Relevance of the effect of oxidized LDL on platelet function
31. Regulated expression of CD36 during monocyte-to-macrophage differentiation: Potential role of CD36 in foam cell formation